Novel Protein Biomarkers of Monoamine Metabolism Defects Correlate with Disease Severity.
Saved in:
| Title: | Novel Protein Biomarkers of Monoamine Metabolism Defects Correlate with Disease Severity. |
|---|---|
| Authors: | Tristán-Noguero A; Synaptic Metabolism Laboratory, Sant Joan de Déu Foundation, Research Pediatric Institute (IPR), Sant Joan de Déu Hospital, Barcelona, Spain., Borràs E; Proteomics Unit, Center for Genomics Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain., Molero-Luis M; Department of Clinical Biochemistry, IPR and CIBERER-ISCIII, Sant Joan de Déu Hospital, Barcelona, Spain., Wassenberg T; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, the Netherlands., Peters T; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, the Netherlands., Verbeek MM; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, the Netherlands.; Department of Pediatric Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, the Netherlands., Willemsen M; Department Laboratory Medicine, Radboud University Medical Center, Nijmegen, the Netherlands., Opladen T; Division of Neuropediatrics & Metabolic Medicine, University Children's Hospital, Heidelberg, Germany., Jeltsch K; Division of Neuropediatrics & Metabolic Medicine, University Children's Hospital, Heidelberg, Germany., Pons R; First Department of Pediatrics, Pediatric Neurology Unit, Agia Sofia Hospital, National and Kapodistrian University of Athens, Athens, Greece., Thony B; Division of Metabolism and Children's Research Centre, University Children's Hospital, Zurich, Switzerland., Horvath G; Department of Pediatrics, University of British Columbia, Vancouver, Canada., Yapici Z; Division of Child Neurology, Department of Neurology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey., Friedman J; Departments of Neuroscience and Pediatrics, University of California, San Diego, California, USA.; Rady Children's Hospital and Rady Children's Institute for Genomic Medicine, San Diego, California, USA., Hyland K; Medical Neurogenetics, LLC, Atlanta, Georgia, USA., Agosta GE; Hospital Italiano de Buenos Aires, Buenos Aires, Argentina., López-Laso E; Pediatric Neurology Unit, Department of Pediatrics, University Hospital Reina Sofía, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), and CIBERER, Córdoba, Spain., Artuch R; Department of Clinical Biochemistry, IPR and CIBERER-ISCIII, Sant Joan de Déu Hospital, Barcelona, Spain., Sabidó E; Proteomics Unit, Center for Genomics Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain., García-Cazorla À; Synaptic Metabolism Laboratory, Sant Joan de Déu Foundation, Research Pediatric Institute (IPR), Sant Joan de Déu Hospital, Barcelona, Spain.; Neurometabolic Unit, Neurology Department, IPR, CIBER ('Centro de investigación Biomédica en Red') of Rare Diseases and Carlos III Healthcare Institute (CIBERER-ISCIII), European Reference Network for Hereditary Metabolic Disorders (MetabERN), Sant Joan de Déu Hospital, Barcelona, Spain. |
| Source: | Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 2021 Mar; Vol. 36 (3), pp. 690-703. Date of Electronic Publication: 2020 Nov 05. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8610688 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1531-8257 (Electronic) Linking ISSN: 08853185 NLM ISO Abbreviation: Mov Disord Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
